文献速递头颈部肿瘤放疗

来那度胺治疗放疗后慢性口腔黏膜炎与软组织坏死

Lenalidomide for the Treatment of Chronic Oral Mucositis and Soft Tissue Necrosis After Radiation Therapy.
PubMed 文献 · Pract Radiat Oncol · 2026-02-18

本文报道2例头颈部肿瘤患者,放疗后出现难治性口腔溃疡(放射性口腔黏膜炎迁延不愈)及软组织坏死,经来那度胺治疗后溃疡完全愈合、症状缓解。原文指出,美国FDA目前尚未批准用于持续性放射性软组织损伤的药物。

要点

  • 2例头颈部肿瘤患者放疗后出现难治性口腔溃疡,使用来那度胺后完全愈合。
  • 放射性口腔黏膜炎可迁延不愈并对常规处理无效,影响生活质量。
  • 目前FDA未批准针对持续性放射性软组织损伤的疗法。

核心结论

  • 来那度胺可能使放疗后难治性口腔溃疡与软组织坏死获得完全愈合和症状缓解。

研究设计与样本

  • 病例报告,描述2例头颈部肿瘤放疗后难治性口腔溃疡患者的诊治经过。

主要发现

  • 2例患者经来那度胺治疗后口腔溃疡完全愈合、症状缓解。

关键数值与推荐

  • 原文未报告来那度胺的剂量、疗程及疗效评价标准。

临床怎么用

  • 对常规处理无效的放疗相关慢性口腔黏膜炎和软组织坏死,可考虑来那度胺,但需更多证据。

局限性

  • 仅为2例病例报告,无对照,无法确立因果关系与适用人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiation-induced oral mucositis is a complication of head and neck cancer therapy that may persist beyond the expected timelines and become refractory to conventional management, adversely affecting patients' quality of life. Radiation therapy for infiltrative tumors can also result in soft tissue necrosis, which may complicate post-treatment recovery. There are currently no therapies approved by the U.S. Food and Drug Administration for persistent radiation-induced soft tissue injury. Herein, we describe 2 patients with head and neck cancer with recalcitrant radiation therapy-associated oral ulcerations who experienced complete healing and resolution of symptoms with lenalidomide therapy.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Pettas E, Woo SB, Margalit DN, et al. Lenalidomide for the Treatment of Chronic Oral Mucositis and Soft Tissue Necrosis After Radiation Therapy. Pract Radiat Oncol. 2026. PMID: 41720302. doi:10.1016/j.prro.2026.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。